Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025
Aida Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 |
|---|---|---|---|---|---|---|
Period Ending | Sep '08 Sep 30, 2008 | Dec '07 Dec 31, 2007 | Dec '06 Dec 31, 2006 | Dec '05 Dec 31, 2005 | Dec '04 Dec 31, 2004 | Dec '03 Dec 31, 2003 |
| Revenue | 40.51 | 29.2 | 29.64 | 24.53 | 15.65 | 12.59 |
| Revenue Growth (YoY) | 41.27% | -1.48% | 20.86% | 56.77% | 24.27% | - |
| Cost of Revenue | 18.2 | 14.56 | 14.3 | 8.39 | 4.82 | 4.77 |
| Gross Profit | 22.3 | 14.64 | 15.34 | 16.14 | 10.82 | 7.82 |
| Selling, General & Admin | 13.25 | 8.91 | 11.08 | 13.98 | 7.7 | 5.77 |
| Research & Development | 0.99 | 0.28 | 0.32 | 0.04 | 0.26 | 0.13 |
| Operating Expenses | 15.28 | 9.2 | 11.4 | 14.02 | 7.97 | 5.9 |
| Operating Income | 7.02 | 5.45 | 3.94 | 2.12 | 2.86 | 1.92 |
| Interest Expense | -2.74 | -2.02 | -1.7 | -1.1 | -0.48 | -0.34 |
| Interest & Investment Income | - | - | - | - | - | 0.12 |
| Other Non Operating Income (Expenses) | 1.28 | 1.04 | 0.09 | 0.44 | 0.16 | 0.27 |
| EBT Excluding Unusual Items | 5.56 | 4.46 | 2.32 | 1.46 | 2.53 | 1.97 |
| Gain (Loss) on Sale of Investments | -0.01 | 0.11 | - | - | - | - |
| Other Unusual Items | 0.11 | 0.11 | - | 0.05 | - | 0.21 |
| Pretax Income | -1.39 | 4.68 | 2.32 | 1.51 | 2.53 | 2.17 |
| Income Tax Expense | -1.08 | 0.36 | 0.17 | 0.14 | 0.15 | 0.71 |
| Earnings From Continuing Operations | -0.31 | 4.32 | 2.15 | 1.36 | 2.38 | 1.47 |
| Earnings From Discontinued Operations | - | - | - | 0.19 | 0.09 | - |
| Net Income to Company | -0.31 | 4.32 | 2.15 | 1.55 | 2.47 | 1.47 |
| Minority Interest in Earnings | -1.87 | -1.58 | -0.7 | -0.08 | -0.84 | -0.13 |
| Net Income | -2.18 | 2.74 | 1.45 | 1.47 | 1.63 | 1.33 |
| Net Income to Common | -2.18 | 2.74 | 1.45 | 1.47 | 1.63 | 1.33 |
| Net Income Growth | - | 88.49% | -1.00% | -10.19% | 22.51% | - |
| Shares Outstanding (Basic) | 27 | 27 | 26 | 23 | 23 | - |
| Shares Outstanding (Diluted) | 27 | 27 | 26 | 23 | 23 | - |
| Shares Change (YoY) | -1.65% | 4.03% | 10.53% | 0.46% | - | - |
| EPS (Basic) | -0.08 | 0.10 | 0.06 | 0.06 | 0.07 | - |
| EPS (Diluted) | -0.08 | 0.10 | 0.06 | 0.06 | 0.07 | - |
| EPS Growth | - | 81.18% | -10.43% | -10.60% | - | - |
| Free Cash Flow | 2.58 | 4.37 | 0.9 | 5.13 | -3.69 | -0.58 |
| Free Cash Flow Per Share | 0.10 | 0.16 | 0.04 | 0.22 | -0.16 | - |
| Gross Margin | 55.06% | 50.13% | 51.75% | 65.80% | 69.17% | 62.09% |
| Operating Margin | 17.34% | 18.65% | 13.28% | 8.64% | 18.25% | 15.25% |
| Profit Margin | -5.38% | 9.38% | 4.90% | 5.99% | 10.45% | 10.60% |
| Free Cash Flow Margin | 6.36% | 14.95% | 3.03% | 20.92% | -23.56% | -4.58% |
| EBITDA | 9.51 | 7.4 | 6.03 | 3.81 | 3.47 | 2.41 |
| EBITDA Margin | 23.49% | 25.34% | 20.33% | 15.54% | 22.15% | 19.18% |
| D&A For EBITDA | 2.49 | 1.96 | 2.09 | 1.69 | 0.61 | 0.49 |
| EBIT | 7.02 | 5.45 | 3.94 | 2.12 | 2.86 | 1.92 |
| EBIT Margin | 17.34% | 18.65% | 13.28% | 8.64% | 18.25% | 15.25% |
| Effective Tax Rate | - | 7.69% | 7.46% | 9.59% | 5.96% | 32.48% |
| Advertising Expenses | - | 0.49 | 0.58 | 0.13 | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.